SAN CARLOS, Calif., Feb 01, 2007 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) announced today that its corporate presentation will be webcast live by the Merrill Lynch 2007 Global Pharmaceutical, Biotechnology & Medical Device Conference in New York, on Wednesday, February 7, 2007 at 1:00pm (Eastern Time). The presentation by Lou Drapeau, senior vice president of finance and CFO, may be accessed live on the investor relations' page at www.nektar.com and will be available for two weeks following the webcast.
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading technologies, expertise and manufacturing capabilities. Nektar technology and know-how have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its technologies and expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.
SOURCE: Nektar Therapeutics
Nektar Therapeutics Joyce Strand, 650-631-3138
Copyright Business Wire 2007
News Provided by COMTEX